The Hague: The European Union’s drug regulator said on Wednesday that blood clots should be listed as “unusual side effects” of the AstraZeneca job, but that the benefits far outweighed the risks as vaccine shortages in many countries Despite the recent rise of the virus.
Several countries have previously suspended the use of the AstraZeneca vaccine for the young population, following a total ban on blood clotting in several places. The United Kingdom said on Wednesday that people under the age of 30 should choose an alternative to the vaccine, after which 19 people died in the collision.
The vaccine’s rise comes at a time when countries traveling from Germany to Ukraine and India are experiencing new waves of infection and death from the virus, which now affects more than 280,000 people worldwide. Has taken his life.
Governments are scrambling to secure surplus doses of the vaccine, with a minority complaint being lodged with Australia, which has blamed it on EU export controls. The European Medicines Agency (EMA) said Wednesday that blood clots should be listed as an “extremely rare” side effect, encouraging countries to continue using them.
The announcement came after the EMA’s safety committee examined reports of blood clots, but EMA chief Emer Cook said no specific risk factor had been identified and that the blockade could be vaccinated. Can be linked to the immune response.
“Specific risk factors such as age, gender or medical history have not been confirmed, as rare cases are seen at all ages,” he told a news conference. He added: “The benefits of the Asterisk vaccine in preventing Covid-19 outweigh the risk of side effects. It is saving lives.” Canada, France, Germany and the Netherlands are among the many countries that can help small people. Not recommending shooting.
The United Kingdom has called on people under the age of 30 to use vaccines other than AstraZeneca, following reports of 79 blood clots and 19 deaths in 20 million doses. He did not say how many people were vaccinated with the AstraZeneca vaccine. AstraZeneca vaccines have been given in at least 111 countries, far more than its competitors, according to AFP. It is being used extensively in rich and poor countries as part of the WHO-backed CWACS scheme to ensure adequate access to vaccines.
The jaw-dropping conflict has sparked a global vaccine that governments hope will help countries emerge from an epidemic that has devastated the global economy and to some extent imprisoned humanity. Severely affected France has imposed tough measures this week, while Ukraine on Wednesday reported new deaths and hospitalizations following drastic measures in the capital.
Kiev Mayor Vitaly Klitschko said: “It is not an exaggeration to call this a critical situation,” warning that the city’s hospitals would soon run out of beds. India, which has a 24-hour record of about 111,000 new cases on Wednesday, said it would also lift stricter curfews in 20 cities, including the capital New Delhi.
As millions of people prepare for new anti-virus principles in India, the country’s Serum Institute – the world’s largest vaccine maker – says the government has banned exports to store excess food at home. Once imposed, it needs financial support.
Adar Ponola, CEO of the company, said that the production capacity at the Serum Institute of India – which is creating the AstraZeneca job, is now forced to “put pressure fairly clearly”. Out of the 3.8 million doses of the contracted Zenica vaccine, only 700,000 experienced vaccine problems in Australia.
Prime Minister Scott Morrison blamed the EU for the shortfall. “It’s not a conflict. It’s not a conflict. It’s not an argument. It’s not a conflict. It’s just a simple fact.”
More than 692 million doses of the corona virus have been administered globally, with only a handful of countries moving ahead by a wide margin, according to AFP figures. Israel has vaccinated 61% of its population with a single dose, while the United States has managed to administer 33% of the population with the first shot.